Pathological, oncologic and functional outcomes of radical prostatectomy following active surveillance

Journal of Urology

Volumn 190, Issue 1, 2013, Pages 91-96

  Satkunasivam, Raj ^a   Kulkarni, Girish S ^a,c   Zlotta, Alexander R ^a   Kalnin, Robin ^b   Trachtenberg, John ^a   Fleshner, Neil E ^a   Hamilton, Robert J ^a   Jewett, Michael A S ^a   Finelli, Antonio ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Meridian Software Development   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

prostatectomy; prostatic neoplasms; watchful waiting

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADVERSE OUTCOME; AGE; ARTICLE; CANCER RECURRENCE; COMPARATIVE STUDY; DISEASE COURSE; DISEASE SURVEILLANCE; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATHOLOGY; PRIORITY JOURNAL; PROSTATECTOMY;

EID: 84878843615     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.01.019     Document Type: Article

References (13)

1. T. Wolters, M.J. Roobol, P.J. van Leeuwen A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial J Urol 185 2011 121
2. N. Lawrentschuk, L. Klotz Active surveillance for low-risk prostate cancer: an update Nat Rev Urol 8 2011 312
3. M.R. Cooperberg, P.R. Carroll, L. Klotz Active surveillance for prostate cancer: progress and promise J Clin Oncol 29 2011 3669
4. A. Heidenreich, J. Bellmunt, M. Bolla EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2010 61
5. L. Klotz, L. Zhang, A. Lam Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126
6. R.C. van den Bergh, S. Roemeling, M.J. Roobol Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly Eur Urol 55 2009 1
7. J.J. Tosoian, B.J. Trock, P. Landis Active surveillance program for prostate cancer: an update of the Johns Hopkins experience J Clin Oncol 29 2011 2185
8. R.J. Babaian, A. Toi, K. Kamoi A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy J Urol 163 2000 152
9. M.A. Dall'Era, J.E. Cowan, J. Simko Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment BJU Int 107 2011 1232
10. R.C. van den Bergh, E.W. Steyerberg, A. Khatami Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes? Cancer 116 2010 1281
11. C. Warlick, B.J. Trock, P. Landis Delayed versus immediate surgical intervention and prostate cancer outcome J Natl Cancer Inst 98 2006 355
12. M. Bul, X. Zhu, A. Rannikko Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study Eur Urol 62 2012 195
13. D. Seiler, M. Randazzo, L. Klotz Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol-based active surveillance: results from a contemporary European patient cohort BJU Int 110 2012 195